Niki BioSolutions, Inc. vs Moderna, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $6 M for Niki BioSolutions, Inc., 15022 times as much (market caps of Mar 8, 2026 for Niki BioSolutions, Inc. and Oct 30, 2026 for Moderna, Inc.). Niki BioSolutions, Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.
- Both made a net loss: $1 M for Niki BioSolutions, Inc. and $2.8 B for Moderna, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Niki BioSolutions, Inc. NIKI | Moderna, Inc. MRNA · #275 in the world |
|---|---|---|
| Profile | ||
| Country | 🇬🇧 UK | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2010 | 2010 |
| Size | ||
| Market cap | $6 M* | $90.1 B |
| Revenue | — | $1.9 B |
| Net income | $-1 M▲ best | $-2.8 B |
| Employees | — | 4,700 |
| Valuation | ||
| Price to sales | — | 35.7× |
| Price to book | — | 10.4× |
| Free cash flow yield | — | -2.3% |
| Profitability | ||
| Gross margin | — | 55.4% |
| Operating margin | — | -158.1% |
| Net margin | — | -145.2% |
| Return on equity | -6.2%▲ best | -28.9% |
| Growth | ||
| Revenue growth | — | -39.9% |
| Revenue growth, 3 years a year | — | -53.4% |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Cash | ||
| Free cash flow margin | — | -106.2% |
| Shareholder returns | ||
| Shareholder yield | — | 0.0% |
| Strength scores | ||
| Piotroski F-score | — | 3 of 9 |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Mar 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Niki BioSolutions, Inc. or Moderna, Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $6 M for Niki BioSolutions, Inc., 15022 times as much (market caps of Mar 8, 2026 for Niki BioSolutions, Inc. and Oct 30, 2026 for Moderna, Inc.). Niki BioSolutions, Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Niki BioSolutions, Inc. or Moderna, Inc.?
Both made a net loss: $1 M for Niki BioSolutions, Inc. and $2.8 B for Moderna, Inc.
More about Niki BioSolutions, Inc.
More about Moderna, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.